ANN ELSHEIKH: Open Payments
NPI 1043974389 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 30 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $632
Food & beverage: $538Education: $94
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $244 |
| Sumitomo Pharma America, Inc. | 10 | $221 |
| Organon LLC | 3 | $55 |
| CooperSurgical, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Evofem Biosciences, Inc. | 2 | $23 |
| Biogen, Inc. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: MYFEMBREE, Veozah, NEXPLANON, Paragard T 380A, THINPREP 2000 PROCESSOR, Phexxi, ZURZUVAE, SLYND.
Industry payments across NY — which companies pay providers there.
